BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF. HIV-associated lymphomas and gamma-herpesviruses. Blood. 2009;113:1213-1224. [PMID: 18955561 DOI: 10.1182/blood-2008-09-180315] [Cited by in Crossref: 225] [Cited by in F6Publishing: 200] [Article Influence: 16.1] [Reference Citation Analysis]
Number Citing Articles
1 Ning S. Innate immune modulation in EBV infection. Herpesviridae 2011;2:1. [PMID: 21429244 DOI: 10.1186/2042-4280-2-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
2 Carroll V, Garzino-Demo A. HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape. Pathog Dis 2015;73:ftv044. [PMID: 26121984 DOI: 10.1093/femspd/ftv044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
3 Jamil MO, Mehta A. Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy. Expert Rev Hematol 2016;9:471-7. [PMID: 26808217 DOI: 10.1586/17474086.2016.1146584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
4 Sufiawati I, Tugizov SM. HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread. PLoS One. 2014;9:e88803. [PMID: 24586397 DOI: 10.1371/journal.pone.0088803] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
5 Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ. Estimating the global burden of Epstein-Barr virus-related cancers. J Cancer Res Clin Oncol 2021. [PMID: 34705104 DOI: 10.1007/s00432-021-03824-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Sin SH, Fakhari FD, Dittmer DP. The viral latency-associated nuclear antigen augments the B-cell response to antigen in vivo. J Virol 2010;84:10653-60. [PMID: 20686032 DOI: 10.1128/JVI.00848-10] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
7 Cui X, Snapper CM. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Front Immunol 2021;12:734471. [PMID: 34691042 DOI: 10.3389/fimmu.2021.734471] [Reference Citation Analysis]
8 Berges BK, Tanner A. Modelling of human herpesvirus infections in humanized mice. J Gen Virol 2014;95:2106-17. [PMID: 25053560 DOI: 10.1099/vir.0.067793-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
9 Carbone A, Gloghini A. The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies. Blood 2013;122:459-60. [PMID: 23869078 DOI: 10.1182/blood-2013-05-502799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Kessler AJ, Marcellino BK, Niglio SA, Petersen BE, Malone AK. A Rare Presentation of HIV-Negative Plasmablastic Lymphoma: A Diagnostic Dilemma. Case Rep Hematol 2019;2019:2907317. [PMID: 30906602 DOI: 10.1155/2019/2907317] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Carbone A, Gloghini A, Kwong YL, Younes A. Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy. Ann Hematol 2014;93:1263-77. [PMID: 24870942 DOI: 10.1007/s00277-014-2116-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
12 Hensel M, Goetzenich A, Lutz T, Stoehr A, Moll A, Rockstroh J, Hanhoff N, Jäger H, Mosthaf F. HIV and cancer in Germany. Dtsch Arztebl Int 2011;108:117-22. [PMID: 21403801 DOI: 10.3238/arztebl.2010.0117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
13 Tazi I, Lahlimi FZ. [Human immunodeficiency virus and lymphoma]. Bull Cancer 2021:S0007-4551(21)00180-6. [PMID: 34246454 DOI: 10.1016/j.bulcan.2021.03.014] [Reference Citation Analysis]
14 Sneller M, Lane H. HIV/IL-2 and EBV-associated lymphoproliferative diseases: cause and effect or coincidence?: Editorial. HIV Med 2014;15:1-2. [DOI: 10.1111/hiv.12092] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
15 Gloghini A, Dolcetti R, Carbone A. Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology. Semin Cancer Biol. 2013;23:457-467. [PMID: 23999127 DOI: 10.1016/j.semcancer.2013.08.004] [Cited by in Crossref: 74] [Cited by in F6Publishing: 65] [Article Influence: 8.2] [Reference Citation Analysis]
16 Bax HI, Freeman AF, Anderson VL, Vesterhus P, Laerum D, Pittaluga S, Wilson WH, Holland SM. B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency. J Clin Immunol 2013;33:1062-6. [PMID: 23800860 DOI: 10.1007/s10875-013-9907-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
17 Beatty J. Viral causes of feline lymphoma: Retroviruses and beyond. The Veterinary Journal 2014;201:174-80. [DOI: 10.1016/j.tvjl.2014.05.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
18 Carbone A, Cesarman E, Gloghini A, Drexler HG. Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines. AIDS 2010;24:479-90. [PMID: 20051807 DOI: 10.1097/QAD.0b013e3283365395] [Cited by in Crossref: 46] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
19 Pan Z, Xie Q, Repertinger S, Richendollar BG, Chan WC, Huang Q. Plasmablastic transformation of low-grade CD5+ B-cell lymphoproliferative disorder with MYC gene rearrangements. Human Pathology 2013;44:2139-48. [DOI: 10.1016/j.humpath.2013.04.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
20 Chadburn A, Said J, Gratzinger D, Chan JK, de Jong D, Jaffe ES, Natkunam Y, Goodlad JR. HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3. Am J Clin Pathol 2017;147:171-87. [PMID: 28395104 DOI: 10.1093/ajcp/aqw218] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 9.4] [Reference Citation Analysis]
21 Pielasinski U, Santonja C, Rodríguez-Pinilla SM, Requena L. Extracavitary primary effusion lymphoma presenting as a cutaneous tumor: a case report and literature review. J Cutan Pathol 2014;41:745-53. [PMID: 24917369 DOI: 10.1111/cup.12368] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
22 Carbone A, Gloghini A. Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment. World J Gastroenterol 2013; 19(44): 7874-7879 [PMID: 24307781 DOI: 10.3748/wjg.v19.i44.7874] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
23 Petrara MR, Cattelan AM, Zanchetta M, Sasset L, Freguja R, Gianesin K, Cecchetto MG, Carmona F, De Rossi A. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients. J Clin Virol 2012;53:195-200. [PMID: 22209290 DOI: 10.1016/j.jcv.2011.12.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
24 Wiggill TM, Mayne ES, Willem P. Challenges in lymphoma diagnosis in HIV positive patients in the South African setting. Transfus Apher Sci 2013;49:157-62. [PMID: 23981653 DOI: 10.1016/j.transci.2013.07.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
25 Shepherd L, Ryom L, Law M, Hatleberg CI, de Wit S, Monforte AD, Battegay M, Phillips A, Bonnet F, Reiss P, Pradier C, Grulich A, Sabin C, Lundgren J, Mocroft A. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma. J Natl Cancer Inst 2018;110:598-607. [PMID: 29267895 DOI: 10.1093/jnci/djx249] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
26 Okada S, Goto H, Yotsumoto M. Current status of treatment for primary effusion lymphoma. Intractable Rare Dis Res 2014;3:65-74. [PMID: 25364646 DOI: 10.5582/irdr.2014.01010] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
27 Carbone A, Volpi CC, Gualeni AV, Gloghini A. Epstein-Barr virus associated lymphomas in people with HIV. Curr Opin HIV AIDS 2017;12:39-46. [PMID: 27755151 DOI: 10.1097/COH.0000000000000333] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
28 Tsai CY, Chen CY, Chiou YH, Shyu HW, Lin KH, Chou MC, Huang MH, Wang YF. Epigallocatechin-3-Gallate Suppresses Human Herpesvirus 8 Replication and Induces ROS Leading to Apoptosis and Autophagy in Primary Effusion Lymphoma Cells. Int J Mol Sci 2017;19:E16. [PMID: 29267216 DOI: 10.3390/ijms19010016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
29 Elyamany G, Al Mussaed E, Alzahrani AM. Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions. Adv Hematol 2015;2015:315289. [PMID: 26357515 DOI: 10.1155/2015/315289] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
30 Purushothaman P, Uppal T, Sarkar R, Verma SC. KSHV-Mediated Angiogenesis in Tumor Progression. Viruses 2016;8:E198. [PMID: 27447661 DOI: 10.3390/v8070198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
31 Pádua D, Rodrigues AC, Barros S, Arruda AL, Castro M, Andrade JL. Cardiac obstruction secondary to metastatic invasion - A rare complication of Human Herpes Virus 8-positive plasmablastic lymphoma in acquired immunodeficiency syndrome. J Thorac Dis 2012;4:425-7. [PMID: 22934146 DOI: 10.3978/j.issn.2072-1439.2012.01.02] [Reference Citation Analysis]
32 Ballestas ME, Kaye KM. The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future Microbiol 2011;6:1399-413. [PMID: 22122438 DOI: 10.2217/fmb.11.137] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 6.4] [Reference Citation Analysis]
33 Lisco A, Vanpouille C, Margolis L. War and peace between microbes: HIV-1 interactions with coinfecting viruses. Cell Host Microbe 2009;6:403-8. [PMID: 19917495 DOI: 10.1016/j.chom.2009.10.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
34 Wahl A, Linnstaedt SD, Esoda C, Krisko JF, Martinez-Torres F, Delecluse HJ, Cullen BR, Garcia JV. A cluster of virus-encoded microRNAs accelerates acute systemic Epstein-Barr virus infection but does not significantly enhance virus-induced oncogenesis in vivo. J Virol 2013;87:5437-46. [PMID: 23468485 DOI: 10.1128/JVI.00281-13] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
35 Zhang Y, Gao B, Duan Y, Deng G, Yang Q, Wang L, Wu P, Zhang L, Sun J, Pan Y. [Preliminary study of microRNA expression profiles in HIV related diffuse large B-cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi 2015;36:337-40. [PMID: 25916299 DOI: 10.3760/cma.j.issn.0253-2727.2015.04.017] [Reference Citation Analysis]
36 Chen Y, Fachko D, Ivanov NS, Skinner CM, Skalsky RL. Epstein-Barr virus microRNAs regulate B cell receptor signal transduction and lytic reactivation. PLoS Pathog 2019;15:e1007535. [PMID: 30615681 DOI: 10.1371/journal.ppat.1007535] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
37 Kariya Y, Hamatake M, Urano E, Yoshiyama H, Shimizu N, Komano J. Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome. Cancer Sci 2010;101:876-81. [PMID: 20132216 DOI: 10.1111/j.1349-7006.2009.01474.x] [Reference Citation Analysis]
38 Chadburn A. Immunodeficiency-associated lymphoid proliferations (ALPS, HIV, and KSHV/HHV8). Seminars in Diagnostic Pathology 2013;30:113-29. [DOI: 10.1053/j.semdp.2012.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
39 Zuo S, Xu N, Li Z, Li N, Xia H, Ren H, Bao H. Clinical Analysis of Five Cases of AIDS-related Non-Hodgkin Lymphoma. Pak J Med Sci 2016;32:1574-9. [PMID: 28083067 DOI: 10.12669/pjms.326.10172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
40 Capello D, Scandurra M, Poretti G, Rancoita PM, Mian M, Gloghini A, Deambrogi C, Martini M, Rossi D, Greiner TC, Chan WC, Ponzoni M, Moreno SM, Piris MA, Canzonieri V, Spina M, Tirelli U, Inghirami G, Rinaldi A, Zucca E, Favera RD, Cavalli F, Larocca LM, Kwee I, Carbone A, Gaidano G, Bertoni F. Genome wide DNA-profiling of HIV-related B-cell lymphomas. Br J Haematol 2010;148:245-55. [PMID: 19832807 DOI: 10.1111/j.1365-2141.2009.07943.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
41 Hamada Y, Nagata N, Honda H, Asayama N, Teruya K, Igari T, Kikuchi Y, Oka S. Epstein-Barr virus associated colitis in an HIV-infected patient. AIDS 2012;26:400-2. [PMID: 22217506 DOI: 10.1097/QAD.0b013e32834f411b] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
42 Bugelski PJ, Volk A, Walker MR, Krayer JH, Martin P, Descotes J. Critical Review of Preclinical Approaches to Evaluate the Potential of Immunosuppressive Drugs to Influence Human Neoplasia. Int J Toxicol 2010;29:435-66. [DOI: 10.1177/1091581810374654] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
43 Ghosh SK, Perrine SP, Faller DV. Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies. Adv Virol 2012;2012:509296. [PMID: 22500168 DOI: 10.1155/2012/509296] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
44 Korkolopoulou P, Vassilakopoulos T, Milionis V, Ioannou M. Recent Advances in Aggressive Large B-cell Lymphomas: A Comprehensive Review. Adv Anat Pathol 2016;23:202-43. [PMID: 27271843 DOI: 10.1097/PAP.0000000000000117] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
45 Eszes N, Tamási L, Csekeő A, Csomor J, Szepesi A, Varga G, Balázs G, Losonczy G, Müller V. Unicentric mixed variant Castleman disease associated with intrabronchial plasmacytoma. Diagn Pathol 2014;9:64. [PMID: 24649966 DOI: 10.1186/1746-1596-9-64] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
46 Paul AG, Chandran B, Sharma-Walia N. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies. Transl Res 2013;162:77-92. [PMID: 23567332 DOI: 10.1016/j.trsl.2013.03.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
47 Petrara MR, Penazzato M, Massavon W, Nabachwa S, Nannyonga M, Mazza A, Gianesin K, Del Bianco P, Lundin R, Sumpter C, Zanchetta M, Giaquinto C, De Rossi A. Epstein-Barr Virus Load in Children Infected With Human Immunodeficiency Virus Type 1 in Uganda. Journal of Infectious Diseases 2014;210:392-9. [DOI: 10.1093/infdis/jiu099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
48 Latour S, Fischer A. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases. Immunol Rev 2019;291:174-89. [PMID: 31402499 DOI: 10.1111/imr.12791] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
49 Wang J, Zhang R, Ding X, Jin Y, Qin R, Xia B, Liao Q, Hu H, Song W, Wang Z, Zhang X, Xu J. Pathologically complete remission to combination of invariant NK T cells and anti-CD20 antibody in a refractory HIV+ diffuse large B-cell lymphoma patient. Immunotherapy 2022. [PMID: 35443802 DOI: 10.2217/imt-2021-0247] [Reference Citation Analysis]
50 Robinson MJ, Tuke PW, Erlwein O, Tettmar KI, Kaye S, Naresh KN, Patel A, Walker MM, Kimura T, Gopalakrishnan G, Tedder RS, McClure MO. No Evidence of XMRV or MuLV Sequences in Prostate Cancer, Diffuse Large B-Cell Lymphoma, or the UK Blood Donor Population. Adv Virol 2011;2011:782353. [PMID: 22312352 DOI: 10.1155/2011/782353] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
51 Ramos JC, Lossos IS. Newly emerging therapies targeting viral-related lymphomas. Curr Oncol Rep 2011;13:416-26. [PMID: 21792540 DOI: 10.1007/s11912-011-0186-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
52 Papoudou-Bai A, Hatzimichael E, Barbouti A, Kanavaros P. Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms. Clin Exp Med 2017;17:291-304. [PMID: 27600282 DOI: 10.1007/s10238-016-0436-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
53 Hu Z, Blackman MA, Kaye KM, Usherwood EJ. Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68. J Immunol 2015;194:2746-56. [PMID: 25662997 DOI: 10.4049/jimmunol.1401928] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
54 Reid EG. Bortezomib-induced Epstein-Barr virus and Kaposi sarcoma herpesvirus lytic gene expression: oncolytic strategies. Curr Opin Oncol 2011;23:482-7. [PMID: 21788895 DOI: 10.1097/CCO.0b013e3283499c37] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
55 Musinova YR, Sheval EV, Dib C, Germini D, Vassetzky YS. Functional roles of HIV-1 Tat protein in the nucleus. Cell Mol Life Sci 2016;73:589-601. [PMID: 26507246 DOI: 10.1007/s00018-015-2077-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
56 Tumwine LK, Orem J, Kerchan P, Byarugaba W, Pileri SA. EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda. Infect Agent Cancer 2010;5:12. [PMID: 20591151 DOI: 10.1186/1750-9378-5-12] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
57 Gloghini A, Volpi CC, Caccia D, Gualeni AV, Cilia AM, Carbone A, Bongarzone I. Primary effusion lymphoma: secretome analysis reveals novel candidate biomarkers with potential pathogenetic significance. Am J Pathol 2014;184:618-30. [PMID: 24521760 DOI: 10.1016/j.ajpath.2013.11.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
58 Juskevicius D, Dietsche T, Lorber T, Rufle A, Ruiz C, Mickys U, Krasniqi F, Dirnhofer S, Tzankov A. Extracavitary primary effusion lymphoma: clinical, morphological, phenotypic and cytogenetic characterization using nuclei enrichment technique. Histopathology 2014;65:693-706. [PMID: 25139766 DOI: 10.1111/his.12478] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
59 Lupo J, Germi R, Lancar R, Algarte-Genin M, Hendel-Chavez H, Taoufik Y, Mounier N, Partisani M, Bonnet F, Meyohas MC, Marchou B, Semanova T, Prevot S, Costagliola D, Morand P, Besson C. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era. AIDS 2019;33:993-1000. [PMID: 30946153 DOI: 10.1097/QAD.0000000000002129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Paul AG, Sharma-Walia N, Chandran B. Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma. PLoS One 2011;6:e24379. [PMID: 21980345 DOI: 10.1371/journal.pone.0024379] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
61 Bruce AG, Bielefeldt-Ohmann H, Barcy S, Bakke AM, Lewis P, Tsai CC, Murnane RD, Rose TM. Macaque homologs of EBV and KSHV show uniquely different associations with simian AIDS-related lymphomas. PLoS Pathog 2012;8:e1002962. [PMID: 23055934 DOI: 10.1371/journal.ppat.1002962] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
62 Besson C, Lancar R, Prevot S, Brice P, Meyohas MC, Marchou B, Gabarre J, Bonnet F, Goujard C, Lambotte O, Boué F, Mounier N, Partisani M, Raffi F, Costello R, Hendel-Chavez H, Algarte-Genin M, Trabelsi S, Marchand L, Raphael M, Taoufik Y, Costagliola D. High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort. Clin Infect Dis 2015;61:1469-75. [PMID: 26223997 DOI: 10.1093/cid/civ627] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
63 Stahl JA, Chavan SS, Sifford JM, MacLeod V, Voth DE, Edmondson RD, Forrest JC. Phosphoproteomic analyses reveal signaling pathways that facilitate lytic gammaherpesvirus replication. PLoS Pathog 2013;9:e1003583. [PMID: 24068923 DOI: 10.1371/journal.ppat.1003583] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
64 Günther T, Grundhoff A. Epigenetic manipulation of host chromatin by Kaposi sarcoma-associated herpesvirus: a tumor-promoting factor? Curr Opin Virol 2017;26:104-11. [PMID: 28802146 DOI: 10.1016/j.coviro.2017.07.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
65 Schulz TF. Cancer and viral infections in immunocompromised individuals. Int J Cancer. 2009;125:1755-1763. [PMID: 19588503 DOI: 10.1002/ijc.24741] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 6.2] [Reference Citation Analysis]
66 Rios A. HIV-related hematological malignancies: a concise review. Clin Lymphoma Myeloma Leuk 2014;14 Suppl:S96-103. [PMID: 25486964 DOI: 10.1016/j.clml.2014.06.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
67 Sin SH, Dittmer DP. Cytokine homologs of human gammaherpesviruses. J Interferon Cytokine Res 2012;32:53-9. [PMID: 22142220 DOI: 10.1089/jir.2011.0083] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
68 Colonna A, Gualco G, Bacchi CE, Leite MA, Rocco M, DeMaglio G, Pizzolitto S, Falconieri G. Plasma cell myeloma presenting with diffuse pleural involvement: a hitherto unreported pattern of a new mesothelioma mimicker. Ann Diagn Pathol 2010;14:30-5. [PMID: 20123454 DOI: 10.1016/j.anndiagpath.2009.10.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
69 Kilfoil KM, Mayne E, Scott L, Stevens W. A High Burden Human Immunodeficiency Virus and Tuberculosis Resource Limited Setting, Gains from Including Xpert MTB/RIF in the Diagnostic Algorithm of Fluid Specimens Submitted for Exclusion of Lymphoma by Immunophenotypic Analysis. PLoS One 2015;10:e0134404. [PMID: 26280548 DOI: 10.1371/journal.pone.0134404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
70 Ramos JC, Sparano JA, Rudek MA, Moore PC, Cesarman E, Reid EG, Henry D, Ratner L, Aboulafia D, Lee JY, Ambinder RF, Mitsuyasu R, Noy A. Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clin Lymphoma Myeloma Leuk 2018;18:180-190.e2. [PMID: 29426719 DOI: 10.1016/j.clml.2018.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
71 Boy S, van Heerden M, Pool R, Willem P, Slavik T. Plasmablastic lymphoma versus diffuse large B cell lymphoma with plasmablastic differentiation: proposal for a novel diagnostic scoring system. J Hematopathol 2015;8:3-11. [DOI: 10.1007/s12308-014-0227-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Taylor GS, Blackbourn DJ. Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV. Cancer Lett 2011;305:263-78. [PMID: 21470769 DOI: 10.1016/j.canlet.2010.08.019] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
73 Yang D, Chen W, Xiong J, Sherrod CJ, Henry DH, Dittmer DP. Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma. Proc Natl Acad Sci U S A 2014;111:E4762-8. [PMID: 25341731 DOI: 10.1073/pnas.1405423111] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
74 Punj V, Matta H, Chaudhary PM. A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma. PLoS One 2012;7:e37498. [PMID: 22624040 DOI: 10.1371/journal.pone.0037498] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
75 Carbone A, Santoro A. How I treat: diagnosing and managing "in situ" lymphoma. Blood 2011;117:3954-60. [PMID: 21224472 DOI: 10.1182/blood-2010-10-299628] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
76 Lurain K, Ramaswami R, Mangusan R, Widell A, Ekwede I, George J, Ambinder R, Cheever M, Gulley JL, Goncalves PH, Wang HW, Uldrick TS, Yarchoan R. Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphoma. J Immunother Cancer 2021;9:e002097. [PMID: 33608378 DOI: 10.1136/jitc-2020-002097] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
77 Taramasso L, Boisson-Dupuis S, Garrè ML, Bondi E, Cama A, Nozza P, Morana G, Casanova JL, Marazzi MG. Pineal germinoma in a child with interferon-γ receptor 1 deficiency. case report and literature review. J Clin Immunol 2014;34:922-7. [PMID: 25216720 DOI: 10.1007/s10875-014-0098-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
78 Uppal T, Jha HC, Verma SC, Robertson ES. Chromatinization of the KSHV Genome During the KSHV Life Cycle. Cancers (Basel) 2015;7:112-42. [PMID: 25594667 DOI: 10.3390/cancers7010112] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
79 Kimani SM, Painschab MS, Horner MJ, Muchengeti M, Fedoriw Y, Shiels MS, Gopal S. Epidemiology of haematological malignancies in people living with HIV. Lancet HIV 2020;7:e641-51. [PMID: 32791045 DOI: 10.1016/S2352-3018(20)30118-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
80 Gwiti P, Jenkins M, Sutak J, Melegh Z. Two cases of rare HHV8-driven intravascular lymphoma with synchronous Kaposi sarcoma, both diagnosed at autopsy in renal transplant recipients. Autops Case Rep 2020;10:e2020206. [PMID: 33344322 DOI: 10.4322/acr.2020.206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
81 Goto H, Okada S. New approaches to treating primary effusion lymphoma. Expert Opinion on Orphan Drugs 2013;1:1019-29. [DOI: 10.1517/21678707.2013.852467] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
82 Vedham V, Verma M, Mahabir S. Early-life exposures to infectious agents and later cancer development. Cancer Med 2015;4:1908-22. [PMID: 26377256 DOI: 10.1002/cam4.538] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
83 Goto H, Kojima Y, Nagai H, Okada S. Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma. Int J Hematol 2013;97:624-33. [PMID: 23605439 DOI: 10.1007/s12185-013-1339-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
84 Bibas M, Antinori A. EBV and HIV-Related Lymphoma. Mediterr J Hematol Infect Dis 2009;1:e2009032. [PMID: 21416008 DOI: 10.4084/MJHID.2009.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
85 Sun SC, Cesarman E. NF-κB as a target for oncogenic viruses. Curr Top Microbiol Immunol 2011;349:197-244. [PMID: 20845110 DOI: 10.1007/82_2010_108] [Cited by in Crossref: 13] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
86 Cohen J, Bagg A, King R, White A, Rossi S, Henry D. Extracavitary primary effusion lymphoma in an HIV-positive patient with Kaposi sarcoma-associated. Community Oncology 2009;6:523-5. [DOI: 10.1016/s1548-5315(11)70364-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Russell MD, Singh-Ranger D, Crosbie J. An AIDS-defining neoplasm in a 30-year-old man on highly active antiretroviral therapy: a forgotten diagnosis? BMJ Case Rep 2014;2014:bcr2013202669. [PMID: 24671319 DOI: 10.1136/bcr-2013-202669] [Reference Citation Analysis]
88 Dong X, Feng H, Sun Q, Li H, Wu TT, Sun R, Tibbetts SA, Chen ZJ, Feng P. Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication. PLoS Pathog 2010;6:e1001001. [PMID: 20686657 DOI: 10.1371/journal.ppat.1001001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
89 Tumwine LK, Orem J, Ayers LW. EBV-Positive Grey Zone Lymphoma in an HIV Infected Man from Kampala, Uganda: Case Report. Int J Med Pharm Case Reports 2014;2:110-6. [PMID: 25599090 DOI: 10.9734/IJMPCR/2015/13625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
90 Rezk SA, Weiss LM. EBV-Associated Lymphoproliferative Disorders: Update in Classification. Surg Pathol Clin 2019;12:745-70. [PMID: 31352986 DOI: 10.1016/j.path.2019.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
91 Morton LM, Kim CJ, Weiss LM, Bhatia K, Cockburn M, Hawes D, Wang SS, Chang C, Altekruse SF, Engels EA, Cozen W. Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era. Leuk Lymphoma 2014;55:551-7. [PMID: 23772639 DOI: 10.3109/10428194.2013.813499] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
92 Zhang T, Lin H, Minhas V, Zhu W, Wood C, He N. Prevalence and correlates of Kaposi's sarcoma-associated herpesvirus infection in a sample of men who have sex with men in eastern China. Epidemiol Infect 2013;141:1823-30. [DOI: 10.1017/s0950268812002361] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
93 Abayomi EA, Somers A, Grewal R, Sissolak G, Bassa F, Maartens D, Jacobs P, Stefan C, Ayers LW. Impact of the HIV epidemic and Anti-Retroviral Treatment policy on lymphoma incidence and subtypes seen in the Western Cape of South Africa, 2002-2009: preliminary findings of the Tygerberg Lymphoma Study Group. Transfus Apher Sci 2011;44:161-6. [PMID: 21402310 DOI: 10.1016/j.transci.2011.01.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
94 Dholaria B, Alapat D, Pandey T, Agarwal A. Plasmablastic lymphoma of the retroperitoneum in an HIV- and HCV-positive patient: hard to diagnose and harder to treat. Med Oncol 2012;29:3529-34. [DOI: 10.1007/s12032-012-0248-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
95 Shannon-Lowe C, Rickinson A. The Global Landscape of EBV-Associated Tumors. Front Oncol 2019;9:713. [PMID: 31448229 DOI: 10.3389/fonc.2019.00713] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 33.7] [Reference Citation Analysis]
96 Caringella F, Desario C, Lorusso E, Pallante I, Furlanello T, Lanave G, Elia G, Martella V, Iatta R, Barrs VR, Beatty J, Buonavoglia C, Decaro N. Prevalence and risk factors for Felis catus gammaherpesvirus 1 detection in domestic cats in Italy. Vet Microbiol 2019;238:108426. [PMID: 31648722 DOI: 10.1016/j.vetmic.2019.108426] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
97 Carbone A, Gloghini A, Santoro A. In situ follicular lymphoma: pathologic characteristics and diagnostic features. Hematol Oncol 2012;30:1-7. [PMID: 21560142 DOI: 10.1002/hon.993] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
98 Bayraktar UD, Diaz LA, Ashlock B, Toomey N, Cabral L, Bayraktar S, Pereira D, Dittmer DP, Ramos JC. Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas. Leuk Lymphoma 2014;55:786-94. [PMID: 23837493 DOI: 10.3109/10428194.2013.818142] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
99 Leung HJ, Duran EM, Kurtoglu M, Andreansky S, Lampidis TJ, Mesri EA. Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression. Antimicrob Agents Chemother 2012;56:5794-803. [PMID: 22926574 DOI: 10.1128/AAC.01126-12] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
100 Petrara MR, Freguja R, Gianesin K, Zanchetta M, De Rossi A. Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection. Front Microbiol. 2013;4:311. [PMID: 24151490 DOI: 10.3389/fmicb.2013.00311] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
101 Sharma-Walia N, Chandran K, Patel K, Veettil MV, Marginean A. The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis. J Virol 2014;88:2131-56. [PMID: 24335295 DOI: 10.1128/JVI.02786-13] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
102 Santana AL, Oldenburg DG, Kirillov V, Malik L, Dong Q, Sinayev R, Marcu KB, White DW, Krug LT. RTA Occupancy of the Origin of Lytic Replication during Murine Gammaherpesvirus 68 Reactivation from B Cell Latency. Pathogens 2017;6:E9. [PMID: 28212352 DOI: 10.3390/pathogens6010009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
103 McLuckie AJ, Barrs VR, Smith AL, Beatty JA. Detection of Felis catus gammaherpesvirus 1 (FcaGHV1) in peripheral blood B- and T-lymphocytes in asymptomatic, naturally-infected domestic cats. Virology 2016;497:211-6. [PMID: 27497183 DOI: 10.1016/j.virol.2016.07.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
104 Pantanowitz L, Carbone A, Dolcetti R. Microenvironment and HIV-related lymphomagenesis. Seminars in Cancer Biology 2015;34:52-7. [DOI: 10.1016/j.semcancer.2015.06.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
105 Beachler DC, Gellert LL, Jacobson LP, Ambinder RF, Breen EC, Martínez-Maza O, Rabkin CS, Kaslow RA, D'Souza G. Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk. J Acquir Immune Defic Syndr 2011;56:188-92. [PMID: 21116187 DOI: 10.1097/QAI.0b013e3181ff976b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
106 Paul AG, Chandran B, Sharma-Walia N. Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines. Transl Res 2013;161:447-68. [PMID: 23523954 DOI: 10.1016/j.trsl.2013.02.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
107 Sissolak G, Sissolak D, Jacobs P. Human immunodeficiency and Hodgkin lymphoma. Transfus Apher Sci 2010;42:131-9. [PMID: 20138008 DOI: 10.1016/j.transci.2010.01.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
108 Fullwood RA, Low GM, Chase EP, Grasley M, Beal SS, McCrary IM, Daniels CW, Ingersoll K, Berges BK. The Kaposi's sarcoma-associated herpesvirus viral interleukin 6 gene affects metastasis and expression of B cell markers in a murine xenograft model. PLoS One 2018;13:e0204947. [PMID: 30265712 DOI: 10.1371/journal.pone.0204947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
109 Ruiz-cordero R, Lewis J, Blieden C, Campuzano-zuluaga G, Hernandez J, Lossos IS, Ikpatt F, Chapman JR, Vega F. Unusual immunophenotypic variant of large B-cell lymphoma associated with HHV-8 and EBV in an HIV positive patient. Human Pathology: Case Reports 2015;2:49-54. [DOI: 10.1016/j.ehpc.2015.02.002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
110 de Carvalho PS, Leal FE, Soares MA. Clinical and Molecular Properties of Human Immunodeficiency Virus-Related Diffuse Large B-Cell Lymphoma. Front Oncol 2021;11:675353. [PMID: 33996608 DOI: 10.3389/fonc.2021.675353] [Reference Citation Analysis]
111 Hellbacher E, Hjorton K, Backlin C, Enblad G, Sundström C, Baecklund E, Knight A. Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis. Acta Oncol 2019;58:1655-9. [PMID: 31407922 DOI: 10.1080/0284186X.2019.1634833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Bressan S, Pierantoni A, Sharifi S, Facchini S, Quagliarello V, Berretta M, Montopoli M. Chemotherapy-Induced Hepatotoxicity in HIV Patients. Cells 2021;10:2871. [PMID: 34831094 DOI: 10.3390/cells10112871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 De Paoli P, Carbone A. Carcinogenic viruses and solid cancers without sufficient evidence of causal association. Int J Cancer. 2013;133:1517-1529. [PMID: 23280523 DOI: 10.1002/ijc.27995] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
114 Bishop JA, Westra WH. Plasmablastic lymphoma involving the parotid gland. Head Neck Pathol 2010;4:148-51. [PMID: 20512642 DOI: 10.1007/s12105-010-0168-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
115 Epeldegui M, Vendrame E, Martínez-Maza O. HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma. Immunol Res 2010;48:72-83. [PMID: 20717742 DOI: 10.1007/s12026-010-8168-8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
116 Stevenson PG, May JS, Connor V, Efstathiou S. Vaccination against a hit-and-run viral cancer. J Gen Virol 2010;91:2176-85. [PMID: 20573854 DOI: 10.1099/vir.0.023507-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
117 Kim Y, Leventaki V, Bhaijee F, Jackson CC, Medeiros LJ, Vega F. Extracavitary/solid variant of primary effusion lymphoma. Ann Diagn Pathol. 2012;16:441-446. [PMID: 22497739 DOI: 10.1016/j.anndiagpath.2012.03.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
118 Vaubell JI, Sing Y, Ramburan A, Sewram V, Thejpal R, Rapiti N, Ramdial PK. Pediatric plasmablastic lymphoma: a clinicopathologic study. Int J Surg Pathol 2014;22:607-16. [PMID: 24771257 DOI: 10.1177/1066896914531815] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
119 Zuercher E, Butticaz C, Wyniger J, Martinez R, Battegay M, Boffi El Amari E, Dang T, Egger JF, Fehr J, Mueller-Garamvögyi E, Parini A, Schaefer SC, Schoeni-Affolter F, Thurnheer C, Tinguely M, Telenti A, Rothenberger S; Swiss HIV Cohort Study. Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation. PLoS One 2012;7:e32168. [PMID: 22384168 DOI: 10.1371/journal.pone.0032168] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
120 McLuckie AJ, Barrs VR, Wilson B, Westman ME, Beatty JA. Felis Catus Gammaherpesvirus 1 DNAemia in Whole Blood from Therapeutically Immunosuppressed or Retrovirus-Infected Cats. Vet Sci 2017;4:E16. [PMID: 29056675 DOI: 10.3390/vetsci4010016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
121 Uldrick TS, Polizzotto MN, Yarchoan R. Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Curr Opin Oncol 2012;24:495-505. [PMID: 22729151 DOI: 10.1097/CCO.0b013e328355e0f3] [Cited by in Crossref: 59] [Cited by in F6Publishing: 25] [Article Influence: 5.9] [Reference Citation Analysis]
122 Lima M. Cutaneous primary B-cell lymphomas: from diagnosis to treatment. An Bras Dermatol 2015;90:687-706. [PMID: 26560215 DOI: 10.1590/abd1806-4841.20153638] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
123 Stephenson K, Peer S, Govender D, Fagan JJ. Plasmablastic lymphoma of the larynx: report of two cases. J Laryngol Otol 2013;127:96-9. [PMID: 22989926 DOI: 10.1017/S0022215112002149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
124 Kalland KH, Ke XS, Øyan AM. Tumour virology--history, status and future challenges. APMIS 2009;117:382-99. [PMID: 19400863 DOI: 10.1111/j.1600-0463.2009.02452.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
125 Carbone A, Vaccher E, Gloghini A, Pantanowitz L, Abayomi A, de Paoli P, Franceschi S. Diagnosis and management of lymphomas and other cancers in HIV-infected patients. Nat Rev Clin Oncol 2014;11:223-38. [DOI: 10.1038/nrclinonc.2014.31] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 10.1] [Reference Citation Analysis]
126 Rinaldi A, Capello D, Zucca E, Gaidano G, Bertoni F. Genome-wide DNA profiling of HIV-related B-cell lymphomas. Methods Mol Biol 2013;973:213-26. [PMID: 23412793 DOI: 10.1007/978-1-62703-281-0_14] [Reference Citation Analysis]
127 Geldmacher C, Koup RA. Pathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infection. Trends Immunol 2012;33:207-14. [PMID: 22398371 DOI: 10.1016/j.it.2012.01.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
128 Lignitto L, Mattiolo A, Negri E, Persano L, Gianesello L, Chieco-Bianchi L, Calabrò ML. Crosstalk between the mesothelium and lymphomatous cells: insight into the mechanisms involved in the progression of body cavity lymphomas. Cancer Med 2014;3:1-13. [PMID: 24402744 DOI: 10.1002/cam4.159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
129 Hu Z, Zhang W, Usherwood EJ. Regulatory CD8+ T cells associated with erosion of immune surveillance in persistent virus infection suppress in vitro and have a reversible proliferative defect. J Immunol 2013;191:312-22. [PMID: 23733872 DOI: 10.4049/jimmunol.1201773] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
130 Law MF, Chan HN, Leung C, Wong CK, Lai HK, Ha CY, Ng C, Yeung YM, Yip SF. Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment. Arch Med Sci 2017;13:698-701. [PMID: 28507591 DOI: 10.5114/aoms.2017.67290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
131 Varadarajan J, McWilliams MJ, Hughes SH. Treatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations. Proc Natl Acad Sci U S A 2013;110:14747-52. [PMID: 23959861 DOI: 10.1073/pnas.1305066110] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
132 Fuda FS. Case study interpretation--Fort Lauderdale: Case 4. Cytometry B Clin Cytom 2015;88:408-12. [PMID: 24488761 DOI: 10.1002/cyto.b.21153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
133 Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, Weisenburger DD, Martínez-Maza O, Hussain SK, Yang J, Chang ET, Engels EA. Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer 2013;109:280-8. [PMID: 23756857 DOI: 10.1038/bjc.2013.294] [Cited by in Crossref: 86] [Cited by in F6Publishing: 71] [Article Influence: 9.6] [Reference Citation Analysis]
134 Azariadis K, Ioannou M, Zachou K, Dalekos GN. An Immunocompetent HIV-Negative Elderly Patient with Low-Grade Fever, Generalized Lymphadenopathy, Splenomegaly, and Acute Phase Response: Do Not Forget Castleman Disease. Case Rep Infect Dis 2021;2021:6614208. [PMID: 33777463 DOI: 10.1155/2021/6614208] [Reference Citation Analysis]
135 Chadburn A, Wilson J, Wang YL. Molecular and Immunohistochemical Detection of Kaposi Sarcoma Herpesvirus/Human Herpesvirus-8. In: Czader M, editor. Hematological Malignancies. Totowa: Humana Press; 2013. pp. 245-56. [DOI: 10.1007/978-1-62703-357-2_18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
136 Gloghini A, Volpi CC, Gualeni AV, Dolcetti R, Bongarzone I, De Paoli P, Carbone A. Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis. Expert Rev Hematol 2017;10:505-14. [PMID: 28468596 DOI: 10.1080/17474086.2017.1326815] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
137 Ambrosio MR, Rocca BJ, Ginori A, Mourmouras V, Amato T, Vindigni C, Lazzi S, Leoncini L. A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study. Am J Clin Pathol 2015;144:817-22. [PMID: 26486748 DOI: 10.1309/AJCP2G0VKTKPNPRR] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
138 Swadley MJ, Deliu M, Mosunjac MB, Gunthel CJ, Nguyen ML, Hanley KZ. Primary and secondary hepatic lymphomas diagnosed by image-guided fine-needle aspiration: a retrospective study of clinical and cytomorphologic findings. Am J Clin Pathol 2014;141:119-27. [PMID: 24343745 DOI: 10.1309/AJCPE58ESCQDZFKX] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
139 Fernandez SG, Miranda JJ. Bendamustine reactivates latent Epstein-Barr virus. Leuk Lymphoma 2016;57:1208-10. [PMID: 26371746 DOI: 10.3109/10428194.2015.1079317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
140 Saba NS, Levy LS. Protein kinase C-beta inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-hodgkin lymphoma cells. J Investig Med 2012;60:29-38. [PMID: 21997316 DOI: 10.2310/JIM.0b013e318237eb55] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
141 Vockerodt M, Yap LF, Shannon-Lowe C, Curley H, Wei W, Vrzalikova K, Murray PG. The Epstein-Barr virus and the pathogenesis of lymphoma. J Pathol. 2015;235:312-322. [PMID: 25294567 DOI: 10.1002/path.4459] [Cited by in Crossref: 113] [Cited by in F6Publishing: 103] [Article Influence: 16.1] [Reference Citation Analysis]
142 Skrabek P, Turner D, Seftel M. Epidemiology of non-Hodgkin lymphoma. Transfus Apher Sci 2013;49:133-8. [PMID: 23958141 DOI: 10.1016/j.transci.2013.07.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
143 Hübel K. The Changing Landscape of Lymphoma Associated with HIV Infection. Curr Oncol Rep 2020;22:111. [PMID: 32803474 DOI: 10.1007/s11912-020-00973-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
144 Dasanu CA, Bauer F, Codreanu I, Padmanabhan P, Rampurwala M. Plasmablastic haemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib: Plasmablastic lymphoma responding to bortezomib. Hematol Oncol 2013;31:164-6. [DOI: 10.1002/hon.2024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
145 Dong X, He Z, Durakoglugil D, Arneson L, Shen Y, Feng P. Murine gammaherpesvirus 68 evades host cytokine production via replication transactivator-induced RelA degradation. J Virol 2012;86:1930-41. [PMID: 22130545 DOI: 10.1128/JVI.06127-11] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
146 Dolcetti R, Gloghini A, Caruso A, Carbone A. A lymphomagenic role for HIV beyond immune suppression? Blood 2016;127:1403-9. [PMID: 26773045 DOI: 10.1182/blood-2015-11-681411] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 10.0] [Reference Citation Analysis]
147 Rainy N, Zayoud M, Kloog Y, Rechavi O, Goldstein I. Viral oncomiR spreading between B and T cells is employed by Kaposi's sarcoma herpesvirus to induce non-cell-autonomous target gene regulation. Oncotarget 2016;7:41870-84. [PMID: 27248822 DOI: 10.18632/oncotarget.9627] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
148 Linke-Serinsöz E, Fend F, Quintanilla-Martinez L. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point. Semin Diagn Pathol 2017;34:352-63. [PMID: 28506687 DOI: 10.1053/j.semdp.2017.04.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
149 Leal FE, Premeaux TA, Abdel-Mohsen M, Ndhlovu LC. Role of Natural Killer Cells in HIV-Associated Malignancies. Front Immunol 2017;8:315. [PMID: 28377768 DOI: 10.3389/fimmu.2017.00315] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
150 Slyker JA, Casper C, Tapia K, Richardson B, Bunts L, Huang ML, Wamalwa D, Benki-Nugent S, John-Stewart G. Accelerated suppression of primary Epstein-Barr virus infection in HIV-infected infants initiating lopinavir/ritonavir-based versus nevirapine-based combination antiretroviral therapy. Clin Infect Dis 2014;58:1333-7. [PMID: 24550373 DOI: 10.1093/cid/ciu088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
151 De Paoli P, Carbone A. Microenvironmental abnormalities induced by viral cooperation: Impact on lymphomagenesis. Seminars in Cancer Biology 2015;34:70-80. [DOI: 10.1016/j.semcancer.2015.03.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
152 Moatamed NA, Song SX, Apple SK, Said JW. Primary effusion lymphoma involving the cerebrospinal fluid. Diagn Cytopathol 2012;40:635-8. [PMID: 21381228 DOI: 10.1002/dc.21653] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
153 Minarovits J, Niller HH. Current Trends and Alternative Scenarios in EBV Research. Methods Mol Biol 2017;1532:1-32. [PMID: 27873264 DOI: 10.1007/978-1-4939-6655-4_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
154 de Leval L. Herpesvirus-Associated B-cell Proliferations. Surgical Pathology Clinics 2010;3:989-1033. [DOI: 10.1016/j.path.2010.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
155 Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab-Traub N, Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 2004;14:453-471. [PMID: 15489139 DOI: 10.1016/j.semcancer.2014.04.004] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 6.1] [Reference Citation Analysis]
156 Tugizov SM, Webster-Cyriaque JY, Syrianen S, Chattopadyay A, Sroussi H, Zhang L, Kaushal A. Mechanisms of viral infections associated with HIV: workshop 2B. Adv Dent Res 2011;23:130-6. [PMID: 21441494 DOI: 10.1177/0022034511400076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
157 Baadani AM, Ballool S, Alhemyadi S, Sallam L, ALsufyani E, Alghamdi A, Alfahad W. The clinical outcome of HIV infection at a tertiary care center in Riyadh, Saudi Arabia. Saudi Med J 2020;41:965-70. [PMID: 32893278 DOI: 10.15537/smj.2020.9.25274] [Reference Citation Analysis]
158 Terrier B, Costagliola D, Prevot S, Chavez H, Missy P, Rince P, Costello R, Escaut L, Gabarre J, Joly B. Characteristics of B-cell lymphomas in HIV/HCV-coinfected patients during the combined antiretroviral therapy era: an ANRS CO16 LYMPHOVIR cohort study. J Acquir Immune Defic Syndr. 2013;63:249-253. [PMID: 23403861 DOI: 10.1097/qai.0b013e31828a77f0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
159 Pratesi C, Zanussi S, Tedeschi R, Bortolin MT, Talamini R, Rupolo M, Scaini C, Basaglia G, Di Maso M, Mazzucato M, Zanet E, Tirelli U, Michieli M, Carbone A, De Paoli P. γ-Herpesvirus load as surrogate marker of early death in HIV-1 lymphoma patients submitted to high dose chemotherapy and autologous peripheral blood stem cell transplantation. PLoS One 2015;10:e0116887. [PMID: 25668032 DOI: 10.1371/journal.pone.0116887] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
160 Arce J, Broadway K, Somma J, Khader S. A case of plasmablastic lymphoma diagnosed on liquid-based pap test. Diagn Cytopathol 2014;42:956-8. [PMID: 24273019 DOI: 10.1002/dc.23063] [Reference Citation Analysis]
161 Bhatt S, Ashlock BM, Toomey NL, Diaz LA, Mesri EA, Lossos IS, Ramos JC. Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma. J Clin Invest 2013;123:2616-28. [PMID: 23635777 DOI: 10.1172/JCI64503] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
162 Robinson BA, O'Connor MA, Li H, Engelmann F, Poland B, Grant R, DeFilippis V, Estep RD, Axthelm MK, Messaoudi I, Wong SW. Viral interferon regulatory factors are critical for delay of the host immune response against rhesus macaque rhadinovirus infection. J Virol 2012;86:2769-79. [PMID: 22171275 DOI: 10.1128/JVI.05657-11] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
163 Rezk SA, Zhao X, Weiss LM. Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update. Hum Pathol 2018;79:18-41. [PMID: 29885408 DOI: 10.1016/j.humpath.2018.05.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
164 Noy A. HIV Lymphoma and Burkitts Lymphoma. Cancer J 2020;26:260-8. [PMID: 32496459 DOI: 10.1097/PPO.0000000000000448] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Schulz TF, Cesarman E. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis. Curr Opin Virol 2015;14:116-28. [PMID: 26431609 DOI: 10.1016/j.coviro.2015.08.016] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 11.4] [Reference Citation Analysis]
166 Gatto F, Cassina G, Broccolo F, Morreale G, Lanino E, Di Marco E, Vardas E, Bernasconi D, Buttò S, Principi N, Esposito S, Scarlatti G, Lusso P, Malnati MS. A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2. J Virol Methods 2011;178:98-105. [PMID: 21903135 DOI: 10.1016/j.jviromet.2011.08.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
167 Noy A. Optimizing treatment of HIV-associated lymphoma. Blood 2019;134:1385-94. [PMID: 30992269 DOI: 10.1182/blood-2018-01-791400] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
168 Liang X, Paden CR, Morales FM, Powers RP, Jacob J, Speck SH. Murine gamma-herpesvirus immortalization of fetal liver-derived B cells requires both the viral cyclin D homolog and latency-associated nuclear antigen. PLoS Pathog 2011;7:e1002220. [PMID: 21931547 DOI: 10.1371/journal.ppat.1002220] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
169 Shah S, Bush LM. Primary effusion lymphoma in HIV. HIV & AIDS Review 2011;10:87-90. [DOI: 10.1016/j.hivar.2011.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
170 Qunaj L, Castillo JJ, Olszewski AJ. Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base. Leuk Lymphoma 2018;59:1375-83. [PMID: 29019447 DOI: 10.1080/10428194.2017.1387912] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
171 Sperling S, Fiedler P, Lechner M, Pollithy A, Ehrenberg S, Schiefer AI, Kenner L, Feuchtinger A, Kühn R, Swinerd G, Schmidt-Supprian M, Strobl LJ, Zimber-Strobl U. Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells. Blood 2019;133:2597-609. [PMID: 30962205 DOI: 10.1182/blood.2018880138] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
172 Bohlius J, Schmidlin K, Costagliola D, Fätkenheuer G, May M, Caro-Murillo AM, Mocroft A, Bonnet F, Clifford G, Karafoulidou A, Miro JM, Lundgren J, Chene G, Egger M; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group. Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antivir Ther 2009;14:1065-74. [PMID: 20032536 DOI: 10.3851/IMP1462] [Cited by in Crossref: 71] [Cited by in F6Publishing: 29] [Article Influence: 5.9] [Reference Citation Analysis]
173 Coghill AE, Hildesheim A. Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature. Am J Epidemiol 2014;180:687-95. [PMID: 25167864 DOI: 10.1093/aje/kwu176] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 7.1] [Reference Citation Analysis]
174 Novacco M, Kohan NR, Stirn M, Meli ML, Díaz-Sánchez AA, Boretti FS, Hofmann-Lehmann R. Prevalence, Geographic Distribution, Risk Factors and Co-Infections of Feline Gammaherpesvirus Infections in Domestic Cats in Switzerland. Viruses 2019;11:E721. [PMID: 31390829 DOI: 10.3390/v11080721] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
175 Koreishi AF, Saenz AJ, Arcila ME, Hedvat C, Fleming S, Teruya-Feldstein J. Synchronous follicular lymphoma, kaposi sarcoma, and castleman's disease in a HIV-negative patient with EBV and HHV-8 coinfection. Int J Surg Pathol 2011;19:685-91. [PMID: 19661098 DOI: 10.1177/1066896909341803] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
176 Nguyen Q, Bhargava P. KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Case report and review of the literature. Human Pathology: Case Reports 2016;6:19-25. [DOI: 10.1016/j.ehpc.2016.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
177 Wu TT, Qian J, Ang J, Sun R. Vaccine prospect of Kaposi sarcoma-associated herpesvirus. Curr Opin Virol 2012;2:482-8. [PMID: 22795202 DOI: 10.1016/j.coviro.2012.06.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
178 Papoudou-bai A, Hatzimichael E, Kyriazopoulou L, Briasoulis E, Kanavaros P. Rare variants in the spectrum of human herpesvirus 8/Epstein-Barr virus–copositive lymphoproliferations. Human Pathology 2015;46:1566-71. [DOI: 10.1016/j.humpath.2015.06.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
179 Spina M, Gloghini A, Tirelli U, Carbone A. Therapeutic options for HIV-associated lymphomas. Expert Opinion on Pharmacotherapy 2010;11:2471-81. [DOI: 10.1517/14656566.2010.502528] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
180 Carbone A, De Paoli P, Gloghini A, Vaccher E. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies: KSHV-Associated MCD. Int J Cancer 2015;137:251-61. [DOI: 10.1002/ijc.28923] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
181 Lee KS, Groshong SD, Cool CD, Kleinschmidt-DeMasters BK, van Dyk LF. Murine gammaherpesvirus 68 infection of IFNgamma unresponsive mice: a small animal model for gammaherpesvirus-associated B-cell lymphoproliferative disease. Cancer Res 2009;69:5481-9. [PMID: 19531651 DOI: 10.1158/0008-5472.CAN-09-0291] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
182 Chandrasekharan JA, Sharma-Walia N. Arachidonic Acid Derived Lipid Mediators Influence Kaposi's Sarcoma-Associated Herpesvirus Infection and Pathogenesis. Front Microbiol 2019;10:358. [PMID: 30915039 DOI: 10.3389/fmicb.2019.00358] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
183 Gru AA, Piris MA. Re-Defining 'Reactive' lymphadenopathies: How molecular lessons have changed our minds. Semin Diagn Pathol 2018;35:1-3. [PMID: 29273279 DOI: 10.1053/j.semdp.2017.12.002] [Reference Citation Analysis]
184 Li M, Hsiao C, Chen Y, Huang W, Lee Y, Huang H, Lien H. Human herpesvirus 8-associated lymphoma mimicking cutaneous anaplastic large T-cell lymphoma in a patient with human immunodeficiency virus infection. Journal of Cutaneous Pathology 2012;39:274-8. [DOI: 10.1111/j.1600-0560.2011.01814.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
185 Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol 2010;84:11670-8. [PMID: 20844043 DOI: 10.1128/JVI.01248-10] [Cited by in Crossref: 135] [Cited by in F6Publishing: 104] [Article Influence: 11.3] [Reference Citation Analysis]
186 Ma SD, Xu X, Jones R, Delecluse HJ, Zumwalde NA, Sharma A, Gumperz JE, Kenney SC. PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model. PLoS Pathog 2016;12:e1005642. [PMID: 27186886 DOI: 10.1371/journal.ppat.1005642] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 10.3] [Reference Citation Analysis]
187 Contreras-Chavez P, Sanchez-Nadales A, Babets I, Sajjad-Hassan R, Lansigan F. Primary cutaneous B-cell lymphoma-leg type in a young adult with HIV: a case report. Oxf Med Case Reports 2020;2020:omaa110. [PMID: 33269089 DOI: 10.1093/omcr/omaa110] [Reference Citation Analysis]
188 Brandsma D, Bromberg JEC. Primary CNS lymphoma in HIV infection. Handb Clin Neurol 2018;152:177-86. [PMID: 29604975 DOI: 10.1016/B978-0-444-63849-6.00014-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
189 Riva G, Luppi M, Barozzi P, Forghieri F, Potenza L. How I treat HHV8/KSHV-related diseases in posttransplant patients. Blood 2012;120:4150-9. [PMID: 22968461 DOI: 10.1182/blood-2012-04-421412] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
190 Vajdic CM, van Leeuwen MT, Turner JJ, Mcdonald AM, Webster AC, Mcdonald SP, Chapman JR, Kaldor JM, Grulich AE. No excess risk of follicular lymphoma in kidney transplant and HIV-related immunodeficiency. Int J Cancer 2010;127:2732-5. [DOI: 10.1002/ijc.25272] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
191 Rezahosseini O, Hanaei S, Hamadani M, Keshavarz-Fathi M, Rezaei N. The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma. Int Rev Immunol 2018;37:165-73. [PMID: 29257907 DOI: 10.1080/08830185.2017.1405396] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
192 Leone G, Larocca LM, Pizzigallo E. Introducing mediterranean journal of hematology and infectious diseases. Mediterr J Hematol Infect Dis 2009;1:e2009001. [PMID: 21415983 DOI: 10.4084/MJHID.2009.001] [Reference Citation Analysis]
193 Long WY, Zhao GH, Wu Y, Liu Y. Gallic acid inhibits Kaposi's Sarcoma-associated herpesvirus lytic reactivation by suppressing RTA transcriptional activities. Food Sci Nutr 2021;9:847-54. [PMID: 33598168 DOI: 10.1002/fsn3.2048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
194 Tang FY, Chen CY, Shyu HW, Hong S, Chen HM, Chiou YH, Lin KH, Chou MC, Wang LY, Wang YF. Resveratrol induces cell death and inhibits human herpesvirus 8 replication in primary effusion lymphoma cells. Chem Biol Interact 2015;242:372-9. [PMID: 26549478 DOI: 10.1016/j.cbi.2015.10.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
195 Abdallah AO, Bansal M, Kemp SA, Schichman SA, Xiang Z. A unique presentation of unilateral pleural effusion in a patient with a high-grade plasma cell neoplasm. Leuk Lymphoma 2015;56:2989-91. [PMID: 25686646 DOI: 10.3109/10428194.2015.1016934] [Reference Citation Analysis]
196 Wang B, Song B, Oster C, Cao J, Raza A, Wang J. Coexistence of intestinal Kaposi sarcoma and plasmablastic lymphoma in an HIV/AIDS patient: case report and review of the literature. J Gastrointest Oncol. 2016;7:S88-S95. [PMID: 27034819 DOI: 10.3978/j.issn.2078-6891.2015.021] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
197 Ramos JC, Sparano JA, Chadburn A, Reid EG, Ambinder RF, Siegel ER, Moore PC, Rubinstein PG, Durand CM, Cesarman E, Aboulafia D, Baiocchi R, Ratner L, Kaplan L, Capoferri AA, Lee JY, Mitsuyasu R, Noy A. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood 2020;136:1284-97. [PMID: 32430507 DOI: 10.1182/blood.2019003959] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
198 Uldrick TS, Polizzotto MN, Aleman K, Wyvill KM, Marshall V, Whitby D, Wang V, Pittaluga S, O'Mahony D, Steinberg SM, Little RF, Yarchoan R. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease. Blood 2014;124:3544-52. [PMID: 25331113 DOI: 10.1182/blood-2014-07-586800] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 6.9] [Reference Citation Analysis]
199 Yoon S, Ryu KH, Baek HJ, An HJ, Joo YH. Epstein-Barr virus-positive diffuse large B-cell lymphoma with human immunodeficiency virus mimicking complicated frontal sinusitis: A case report. World J Clin Cases 2021; 9(7): 1654-1660 [PMID: 33728309 DOI: 10.12998/wjcc.v9.i7.1654] [Reference Citation Analysis]
200 Ota Y, Hishima T, Mochizuki M, Kodama Y, Moritani S, Oyaizu N, Mine S, Ajisawa A, Tanuma J, Uehira T, Hagiwara S, Yajima K, Koizumi Y, Shirasaka T, Kojima Y, Nagai H, Yokomaku Y, Shiozawa Y, Koibuchi T, Iwamoto A, Oka S, Hasegawa H, Okada S, Katano H. Classification of AIDS-related lymphoma cases between 1987 and 2012 in Japan based on the WHO classification of lymphomas, fourth edition. Cancer Med 2014;3:143-53. [PMID: 24407967 DOI: 10.1002/cam4.178] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
201 Roy D, Sin SH, Damania B, Dittmer DP. Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines. Blood 2011;118:e32-9. [PMID: 21685375 DOI: 10.1182/blood-2010-12-323659] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
202 Perez K, Castillo J, Dezube BJ, Pantanowitz L. Human immunodeficiency virus-associated anaplastic large cell lymphoma. Leukemia & Lymphoma 2010;51:430-8. [DOI: 10.3109/10428190903572201] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
203 Cattaneo C, Re A, Ungari M, Peli A, Casari S, Castelnuovo F, Fisogni S, Lonardi S, Pellegrini V, Petullà M, Facchetti F, Rossi G. Plasmablastic lymphoma among human immunodeficiency virus-positive patients: results of a single center's experience. Leukemia & Lymphoma 2014;56:267-9. [DOI: 10.3109/10428194.2014.911867] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
204 Piselli P, Verdirosi D, Cimaglia C, Busnach G, Fratino L, Ettorre GM, De Paoli P, Citterio F, Serraino D. Epidemiology of de novo malignancies after solid-organ transplantation: immunosuppression, infection and other risk factors. Best Pract Res Clin Obstet Gynaecol 2014;28:1251-65. [PMID: 25209964 DOI: 10.1016/j.bpobgyn.2014.08.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]